Application

18344786 · VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

Filed 2023-06-29 · Abandoned The official file ↗ · Art unit 1647 · Examiner Jon McClelland Lockard Easy · CPC C07K 14/71 · Regeneron Pharmaceuticals, Inc. · A&P - Regeneron (Prosecution)

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

10.5 mo

to disposition 17.0 mo

Statutes raised

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.